Welcome.

Below you will find information about this National Vaccine Research Study for Transplant Recipients


COVID-19 Antibody Testing of Recipients of Solid Organ Transplants and Patients with Chronic Diseases is being led by the transplant team at Johns Hopkins. Our principal investigator is William Werbel, MD Instructor, Johns Hopkins Department of Infectious Disease. The study has been approved by the Johns Hopkins Institutional Review Board (IRB00248540)

The purpose of this research study is to determine COVID-19 antibody levels in transplant recipients
who get the COVID-19 vaccine. The study does not provide the vaccine, and study team members will not be offering guidance as to whether or not one should receive a SARS-CoV-2 vaccine. If participants have received or will be receiving a vaccine and are interested in the study, we will collect a blood sample before vaccination when possible, and collect samples at sequential time points post-immunization.

We are now enrolling patients who have received three doses of COVID-vaccines in our observational study. For more information about potential eligibility, click below or e-mail covidvaccine@jhmi.edu.

Dorry Segev, MD, PhD | William Werbel, MD | Robin Avery, MD | Jacqueline Garonzik-Wang, MD, PhD | Jonathan Mitchell, MBBS | Brian Boyarsky, MD, PhD | Jennifer Alejo , MD |

Copyright Johns Hopkins University, 2021 | Baltimore, MD 21205